Structure

Physi-Chem Properties

Molecular Weight:  183.09
Volume:  185.122
LogP:  0.119
LogD:  0.46
LogS:  -0.576
# Rotatable Bonds:  3
TPSA:  62.58
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  1
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.725
Synthetic Accessibility Score:  2.529
Fsp3:  0.444
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.576
MDCK Permeability:  7.356796231761109e-06
Pgp-inhibitor:  0.001
Pgp-substrate:  0.019
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.089
30% Bioavailability (F30%):  0.148

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.1
Plasma Protein Binding (PPB):  14.773356437683105%
Volume Distribution (VD):  1.351
Pgp-substrate:  73.13582611083984%

ADMET: Metabolism

CYP1A2-inhibitor:  0.049
CYP1A2-substrate:  0.392
CYP2C19-inhibitor:  0.016
CYP2C19-substrate:  0.511
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.148
CYP2D6-inhibitor:  0.008
CYP2D6-substrate:  0.521
CYP3A4-inhibitor:  0.004
CYP3A4-substrate:  0.283

ADMET: Excretion

Clearance (CL):  7.471
Half-life (T1/2):  0.889

ADMET: Toxicity

hERG Blockers:  0.023
Human Hepatotoxicity (H-HT):  0.157
Drug-inuced Liver Injury (DILI):  0.103
AMES Toxicity:  0.349
Rat Oral Acute Toxicity:  0.052
Maximum Recommended Daily Dose:  0.021
Skin Sensitization:  0.878
Carcinogencity:  0.496
Eye Corrosion:  0.003
Eye Irritation:  0.056
Respiratory Toxicity:  0.068

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC263439

Natural Product ID:  NPC263439
Common Name*:   Ginkgotoxin
IUPAC Name:   5-(hydroxymethyl)-4-(methoxymethyl)-2-methylpyridin-3-ol
Synonyms:   Ginkgotoxin
Standard InCHIKey:  SVINQHQHARVZFF-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C9H13NO3/c1-6-9(12)8(5-13-2)7(4-11)3-10-6/h3,11-12H,4-5H2,1-2H3
SMILES:  Cc1c(c(COC)c(cn1)CO)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1076875
PubChem CID:   76581
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000089] Pyridines and derivatives
        • [CHEMONTID:0001948] Pyridoxines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. leaf n.a. DOI[10.1016/S0031-9422(01)00320-X]
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. leaf n.a. PMID[11738417]
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. fruit n.a. PMID[21462031]
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT24311 SINGLE PROTEIN Pyridoxal kinase Homo sapiens Km = 5000.0 nM PMID[483484]
NPT35 Others n.a. LogP = -0.299 n.a. PMID[483484]
NPT614 Tissue Plasma Rattus norvegicus Cp = 1.31 uM PMID[483484]
NPT419 Organism Oryctolagus cuniculus Oryctolagus cuniculus LD50 = 30.0 mg.kg-1 PMID[483484]
NPT621 Tissue Plasma Homo sapiens Drug uptake = 53.0 nM PMID[483484]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC263439 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9732 High Similarity NPC132680
0.9732 High Similarity NPC269919
0.9597 High Similarity NPC63562
0.9346 High Similarity NPC322976
0.9346 High Similarity NPC63338
0.9346 High Similarity NPC324203
0.9103 High Similarity NPC211187
0.8875 High Similarity NPC256828
0.8614 High Similarity NPC325705
0.8614 High Similarity NPC52831
0.8208 Intermediate Similarity NPC36498
0.8101 Intermediate Similarity NPC220523
0.7791 Intermediate Similarity NPC153769
0.7791 Intermediate Similarity NPC194724
0.775 Intermediate Similarity NPC471598
0.7709 Intermediate Similarity NPC3715
0.7658 Intermediate Similarity NPC471596
0.7616 Intermediate Similarity NPC252590
0.761 Intermediate Similarity NPC280853
0.7562 Intermediate Similarity NPC285016
0.7562 Intermediate Similarity NPC245657
0.7558 Intermediate Similarity NPC473764
0.7558 Intermediate Similarity NPC314940
0.7554 Intermediate Similarity NPC224928
0.7546 Intermediate Similarity NPC161292
0.7529 Intermediate Similarity NPC473057
0.7514 Intermediate Similarity NPC219963
0.75 Intermediate Similarity NPC174421
0.7469 Intermediate Similarity NPC470403
0.7469 Intermediate Similarity NPC470394
0.7469 Intermediate Similarity NPC470404
0.7453 Intermediate Similarity NPC318935
0.7442 Intermediate Similarity NPC108469
0.7438 Intermediate Similarity NPC471594
0.7389 Intermediate Similarity NPC42591
0.7378 Intermediate Similarity NPC470395
0.7355 Intermediate Similarity NPC165370
0.7333 Intermediate Similarity NPC320394
0.7318 Intermediate Similarity NPC266551
0.7318 Intermediate Similarity NPC161887
0.7317 Intermediate Similarity NPC471323
0.7297 Intermediate Similarity NPC226202
0.7294 Intermediate Similarity NPC138018
0.7292 Intermediate Similarity NPC316403
0.7283 Intermediate Similarity NPC471178
0.7273 Intermediate Similarity NPC314270
0.7259 Intermediate Similarity NPC470799
0.7259 Intermediate Similarity NPC8022
0.7244 Intermediate Similarity NPC212125
0.7238 Intermediate Similarity NPC284559
0.7219 Intermediate Similarity NPC251090
0.7216 Intermediate Similarity NPC253810
0.7204 Intermediate Similarity NPC289786
0.7193 Intermediate Similarity NPC116573
0.7181 Intermediate Similarity NPC267928
0.7172 Intermediate Similarity NPC477110
0.7167 Intermediate Similarity NPC478032
0.716 Intermediate Similarity NPC284348
0.7151 Intermediate Similarity NPC283152
0.7128 Intermediate Similarity NPC473053
0.7127 Intermediate Similarity NPC470474
0.7119 Intermediate Similarity NPC249614
0.711 Intermediate Similarity NPC25899
0.7105 Intermediate Similarity NPC476167
0.7102 Intermediate Similarity NPC44161
0.71 Intermediate Similarity NPC173080
0.7099 Intermediate Similarity NPC29702
0.7099 Intermediate Similarity NPC328029
0.7098 Intermediate Similarity NPC329708
0.7098 Intermediate Similarity NPC47059
0.7098 Intermediate Similarity NPC118832
0.7098 Intermediate Similarity NPC165349
0.7098 Intermediate Similarity NPC274291
0.7098 Intermediate Similarity NPC264166
0.7069 Intermediate Similarity NPC471177
0.7069 Intermediate Similarity NPC177404
0.7069 Intermediate Similarity NPC124542
0.7069 Intermediate Similarity NPC59779
0.7065 Intermediate Similarity NPC315804
0.7065 Intermediate Similarity NPC313804
0.7059 Intermediate Similarity NPC133140
0.7059 Intermediate Similarity NPC195268
0.7053 Intermediate Similarity NPC192315
0.7052 Intermediate Similarity NPC84508
0.7049 Intermediate Similarity NPC62069
0.7049 Intermediate Similarity NPC207851
0.7047 Intermediate Similarity NPC475774
0.7029 Intermediate Similarity NPC97367
0.7027 Intermediate Similarity NPC46580
0.7025 Intermediate Similarity NPC306397
0.7011 Intermediate Similarity NPC20249
0.7011 Intermediate Similarity NPC314002
0.7006 Intermediate Similarity NPC151489
0.7006 Intermediate Similarity NPC319456
0.7005 Intermediate Similarity NPC5145
0.7 Intermediate Similarity NPC288943
0.6982 Remote Similarity NPC257142
0.6979 Remote Similarity NPC19872
0.6971 Remote Similarity NPC48192
0.6961 Remote Similarity NPC96890
0.6957 Remote Similarity NPC256893
0.6957 Remote Similarity NPC204717
0.6954 Remote Similarity NPC185782
0.6935 Remote Similarity NPC26679
0.6935 Remote Similarity NPC202605
0.6935 Remote Similarity NPC112206
0.6935 Remote Similarity NPC66083
0.6931 Remote Similarity NPC307963
0.6931 Remote Similarity NPC473822
0.6927 Remote Similarity NPC121658
0.6927 Remote Similarity NPC14651
0.6919 Remote Similarity NPC295158
0.6919 Remote Similarity NPC62510
0.6915 Remote Similarity NPC469390
0.6907 Remote Similarity NPC470678
0.6906 Remote Similarity NPC203754
0.6906 Remote Similarity NPC134586
0.6906 Remote Similarity NPC150048
0.6904 Remote Similarity NPC18348
0.6904 Remote Similarity NPC477111
0.6902 Remote Similarity NPC220765
0.6898 Remote Similarity NPC110741
0.6898 Remote Similarity NPC75544
0.6898 Remote Similarity NPC44354
0.6888 Remote Similarity NPC472287
0.6888 Remote Similarity NPC472286
0.6882 Remote Similarity NPC171171
0.6882 Remote Similarity NPC61350
0.6875 Remote Similarity NPC71079
0.6872 Remote Similarity NPC476138
0.6872 Remote Similarity NPC245816
0.6872 Remote Similarity NPC476518
0.6868 Remote Similarity NPC184964
0.6868 Remote Similarity NPC211997
0.6854 Remote Similarity NPC41717
0.6842 Remote Similarity NPC79293
0.6842 Remote Similarity NPC329541
0.6842 Remote Similarity NPC279401
0.6839 Remote Similarity NPC476582
0.6839 Remote Similarity NPC4071
0.6839 Remote Similarity NPC476578
0.6837 Remote Similarity NPC164374
0.6837 Remote Similarity NPC137929
0.6837 Remote Similarity NPC470500
0.6836 Remote Similarity NPC118511
0.6836 Remote Similarity NPC102423
0.6836 Remote Similarity NPC474217
0.6833 Remote Similarity NPC158129
0.6833 Remote Similarity NPC273532
0.6832 Remote Similarity NPC288349
0.6831 Remote Similarity NPC472168
0.6831 Remote Similarity NPC42979
0.6828 Remote Similarity NPC241025
0.6827 Remote Similarity NPC244536
0.6825 Remote Similarity NPC114974
0.6821 Remote Similarity NPC66815
0.6818 Remote Similarity NPC287208
0.6813 Remote Similarity NPC224764
0.6809 Remote Similarity NPC296527
0.6804 Remote Similarity NPC477019
0.6802 Remote Similarity NPC477113
0.6798 Remote Similarity NPC85918
0.6791 Remote Similarity NPC314573
0.6789 Remote Similarity NPC141915
0.6789 Remote Similarity NPC114335
0.6789 Remote Similarity NPC280964
0.6786 Remote Similarity NPC317572
0.6786 Remote Similarity NPC60553
0.6784 Remote Similarity NPC469589
0.678 Remote Similarity NPC174049
0.678 Remote Similarity NPC79911
0.6772 Remote Similarity NPC76748
0.6771 Remote Similarity NPC109922
0.6771 Remote Similarity NPC13880
0.6769 Remote Similarity NPC31930
0.6769 Remote Similarity NPC155792
0.6766 Remote Similarity NPC316981
0.676 Remote Similarity NPC278366
0.676 Remote Similarity NPC127730
0.6753 Remote Similarity NPC287437
0.6753 Remote Similarity NPC128823
0.6751 Remote Similarity NPC16452
0.6751 Remote Similarity NPC472259
0.6751 Remote Similarity NPC36229
0.6751 Remote Similarity NPC476581
0.675 Remote Similarity NPC11464
0.674 Remote Similarity NPC302647
0.6737 Remote Similarity NPC92111
0.6733 Remote Similarity NPC162530
0.6732 Remote Similarity NPC193267
0.6732 Remote Similarity NPC213530
0.6724 Remote Similarity NPC107287
0.6724 Remote Similarity NPC26872
0.6723 Remote Similarity NPC120798
0.672 Remote Similarity NPC32771
0.672 Remote Similarity NPC48938
0.6718 Remote Similarity NPC315957
0.6718 Remote Similarity NPC176538
0.6718 Remote Similarity NPC234197
0.6717 Remote Similarity NPC304183

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC263439 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9732 High Similarity NPD9382 Approved
0.9732 High Similarity NPD9383 Approved
0.9346 High Similarity NPD9398 Clinical (unspecified phase)
0.8614 High Similarity NPD9510 Approved
0.8476 Intermediate Similarity NPD2123 Phase 3
0.8457 Intermediate Similarity NPD1229 Phase 2
0.8208 Intermediate Similarity NPD9364 Phase 2
0.8208 Intermediate Similarity NPD9363 Approved
0.8023 Intermediate Similarity NPD5317 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD9362 Approved
0.7791 Intermediate Similarity NPD9706 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD5751 Clinical (unspecified phase)
0.756 Intermediate Similarity NPD604 Clinical (unspecified phase)
0.7542 Intermediate Similarity NPD5256 Discontinued
0.7429 Intermediate Similarity NPD9690 Approved
0.7427 Intermediate Similarity NPD862 Approved
0.7427 Intermediate Similarity NPD861 Approved
0.7427 Intermediate Similarity NPD863 Approved
0.7418 Intermediate Similarity NPD1213 Phase 3
0.7396 Intermediate Similarity NPD2581 Approved
0.7396 Intermediate Similarity NPD2582 Approved
0.7384 Intermediate Similarity NPD925 Approved
0.7384 Intermediate Similarity NPD926 Approved
0.731 Intermediate Similarity NPD1418 Phase 2
0.7308 Intermediate Similarity NPD1034 Phase 3
0.7308 Intermediate Similarity NPD1033 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD6872 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD1622 Discontinued
0.7267 Intermediate Similarity NPD9506 Approved
0.7257 Intermediate Similarity NPD565 Phase 2
0.7251 Intermediate Similarity NPD5255 Approved
0.7247 Intermediate Similarity NPD6159 Phase 2
0.7244 Intermediate Similarity NPD9284 Approved
0.7243 Intermediate Similarity NPD6569 Phase 2
0.7241 Intermediate Similarity NPD425 Approved
0.7241 Intermediate Similarity NPD424 Approved
0.7209 Intermediate Similarity NPD112 Approved
0.7209 Intermediate Similarity NPD9705 Discontinued
0.7207 Intermediate Similarity NPD1620 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD158 Discontinued
0.7135 Intermediate Similarity NPD5316 Approved
0.7135 Intermediate Similarity NPD8063 Discontinued
0.711 Intermediate Similarity NPD687 Clinical (unspecified phase)
0.7098 Intermediate Similarity NPD4036 Approved
0.7098 Intermediate Similarity NPD31 Approved
0.7098 Intermediate Similarity NPD4035 Approved
0.7098 Intermediate Similarity NPD4037 Approved
0.7098 Intermediate Similarity NPD4034 Approved
0.7098 Intermediate Similarity NPD4038 Approved
0.7098 Intermediate Similarity NPD4033 Approved
0.7098 Intermediate Similarity NPD32 Approved
0.7098 Intermediate Similarity NPD4122 Approved
0.7098 Intermediate Similarity NPD4039 Approved
0.709 Intermediate Similarity NPD2952 Discontinued
0.7059 Intermediate Similarity NPD3922 Approved
0.7059 Intermediate Similarity NPD3923 Approved
0.7059 Intermediate Similarity NPD3924 Approved
0.7059 Intermediate Similarity NPD3921 Approved
0.7037 Intermediate Similarity NPD3478 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD3477 Phase 2
0.7033 Intermediate Similarity NPD7414 Clinical (unspecified phase)
0.7033 Intermediate Similarity NPD4204 Approved
0.7033 Intermediate Similarity NPD4203 Approved
0.703 Intermediate Similarity NPD1649 Discontinued
0.7025 Intermediate Similarity NPD9080 Approved
0.7022 Intermediate Similarity NPD485 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD1078 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD9695 Approved
0.7012 Intermediate Similarity NPD203 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD9076 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD1352 Discontinued
0.6989 Remote Similarity NPD4021 Phase 2
0.6984 Remote Similarity NPD3395 Approved
0.6984 Remote Similarity NPD3396 Approved
0.6979 Remote Similarity NPD4396 Clinical (unspecified phase)
0.6973 Remote Similarity NPD4375 Approved
0.697 Remote Similarity NPD4131 Phase 3
0.6959 Remote Similarity NPD9595 Approved
0.6959 Remote Similarity NPD9596 Approved
0.694 Remote Similarity NPD3386 Phase 2
0.6939 Remote Similarity NPD1392 Approved
0.6931 Remote Similarity NPD4551 Phase 2
0.6931 Remote Similarity NPD1038 Approved
0.6927 Remote Similarity NPD2177 Approved
0.6927 Remote Similarity NPD2176 Approved
0.6927 Remote Similarity NPD2175 Phase 3
0.691 Remote Similarity NPD2781 Approved
0.6905 Remote Similarity NPD3813 Approved
0.6897 Remote Similarity NPD537 Phase 2
0.6897 Remote Similarity NPD9574 Clinical (unspecified phase)
0.6897 Remote Similarity NPD534 Phase 2
0.6893 Remote Similarity NPD2780 Approved
0.6893 Remote Similarity NPD2782 Approved
0.6889 Remote Similarity NPD2077 Approved
0.6889 Remote Similarity NPD2076 Approved
0.6884 Remote Similarity NPD3570 Phase 2
0.6884 Remote Similarity NPD4502 Phase 2
0.6882 Remote Similarity NPD3039 Clinical (unspecified phase)
0.6878 Remote Similarity NPD9689 Approved
0.6872 Remote Similarity NPD4724 Clinical (unspecified phase)
0.6868 Remote Similarity NPD1032 Phase 2
0.6865 Remote Similarity NPD5083 Clinical (unspecified phase)
0.6853 Remote Similarity NPD796 Phase 2
0.6845 Remote Similarity NPD3525 Discontinued
0.6845 Remote Similarity NPD2383 Phase 1
0.6842 Remote Similarity NPD6361 Phase 2
0.6839 Remote Similarity NPD1274 Clinical (unspecified phase)
0.6828 Remote Similarity NPD4889 Approved
0.6827 Remote Similarity NPD6553 Clinical (unspecified phase)
0.6827 Remote Similarity NPD4086 Phase 1
0.6813 Remote Similarity NPD5100 Phase 3
0.6805 Remote Similarity NPD8823 Approved
0.68 Remote Similarity NPD4670 Clinical (unspecified phase)
0.68 Remote Similarity NPD4671 Clinical (unspecified phase)
0.68 Remote Similarity NPD4669 Clinical (unspecified phase)
0.68 Remote Similarity NPD3779 Clinical (unspecified phase)
0.6789 Remote Similarity NPD4372 Phase 1
0.6784 Remote Similarity NPD4703 Approved
0.6784 Remote Similarity NPD4702 Approved
0.6776 Remote Similarity NPD4071 Approved
0.6776 Remote Similarity NPD4072 Approved
0.6776 Remote Similarity NPD2414 Clinical (unspecified phase)
0.6774 Remote Similarity NPD1096 Discontinued
0.6768 Remote Similarity NPD7222 Phase 2
0.6758 Remote Similarity NPD1923 Clinical (unspecified phase)
0.6757 Remote Similarity NPD1783 Clinical (unspecified phase)
0.6754 Remote Similarity NPD4529 Approved
0.6754 Remote Similarity NPD4526 Approved
0.6754 Remote Similarity NPD4528 Approved
0.6753 Remote Similarity NPD5999 Phase 2
0.6737 Remote Similarity NPD4699 Discontinued
0.6737 Remote Similarity NPD4148 Approved
0.6718 Remote Similarity NPD1739 Approved
0.6718 Remote Similarity NPD1740 Approved
0.6715 Remote Similarity NPD8356 Approved
0.6703 Remote Similarity NPD2599 Approved
0.6703 Remote Similarity NPD2600 Approved
0.6703 Remote Similarity NPD2601 Approved
0.67 Remote Similarity NPD4437 Phase 3
0.6699 Remote Similarity NPD5640 Discontinued
0.6687 Remote Similarity NPD9207 Approved
0.6687 Remote Similarity NPD9206 Approved
0.6685 Remote Similarity NPD6641 Approved
0.6685 Remote Similarity NPD6642 Approved
0.6684 Remote Similarity NPD4081 Clinical (unspecified phase)
0.6684 Remote Similarity NPD3321 Discontinued
0.6683 Remote Similarity NPD6290 Phase 2
0.6667 Remote Similarity NPD1304 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4795 Phase 2
0.6667 Remote Similarity NPD5612 Discontinued
0.6667 Remote Similarity NPD9687 Approved
0.6667 Remote Similarity NPD9688 Approved
0.6649 Remote Similarity NPD2334 Discontinued
0.6649 Remote Similarity NPD3082 Discontinued
0.6647 Remote Similarity NPD3717 Discontinued
0.6635 Remote Similarity NPD1856 Discontinued
0.6634 Remote Similarity NPD3939 Suspended
0.663 Remote Similarity NPD5862 Discovery
0.661 Remote Similarity NPD820 Phase 3
0.6601 Remote Similarity NPD7069 Discontinued
0.66 Remote Similarity NPD7452 Approved
0.66 Remote Similarity NPD7453 Approved
0.6597 Remote Similarity NPD2544 Clinical (unspecified phase)
0.6593 Remote Similarity NPD5320 Approved
0.6593 Remote Similarity NPD5319 Approved
0.659 Remote Similarity NPD9271 Approved
0.6589 Remote Similarity NPD7558 Phase 2
0.6588 Remote Similarity NPD8430 Approved
0.6582 Remote Similarity NPD1768 Approved
0.658 Remote Similarity NPD5575 Clinical (unspecified phase)
0.658 Remote Similarity NPD802 Phase 2
0.6579 Remote Similarity NPD6257 Clinical (unspecified phase)
0.6567 Remote Similarity NPD5863 Clinical (unspecified phase)
0.6564 Remote Similarity NPD7948 Phase 1
0.6561 Remote Similarity NPD6344 Clinical (unspecified phase)
0.6559 Remote Similarity NPD1503 Clinical (unspecified phase)
0.6559 Remote Similarity NPD3920 Phase 2
0.6557 Remote Similarity NPD9548 Phase 2
0.6555 Remote Similarity NPD4945 Discontinued
0.6552 Remote Similarity NPD5067 Phase 2
0.6552 Remote Similarity NPD5936 Approved
0.6552 Remote Similarity NPD5066 Phase 2
0.6552 Remote Similarity NPD5939 Approved
0.6548 Remote Similarity NPD484 Approved
0.6545 Remote Similarity NPD9714 Clinical (unspecified phase)
0.6531 Remote Similarity NPD7889 Clinical (unspecified phase)
0.6526 Remote Similarity NPD4921 Phase 3
0.6526 Remote Similarity NPD4920 Clinical (unspecified phase)
0.6526 Remote Similarity NPD4919 Phase 3
0.6522 Remote Similarity NPD5948 Phase 2
0.652 Remote Similarity NPD3815 Phase 1
0.652 Remote Similarity NPD3816 Phase 1
0.6512 Remote Similarity NPD6494 Phase 2
0.6508 Remote Similarity NPD3569 Discontinued
0.65 Remote Similarity NPD1685 Approved
0.65 Remote Similarity NPD1684 Approved
0.6497 Remote Similarity NPD4548 Discontinued
0.6488 Remote Similarity NPD2616 Phase 3
0.6488 Remote Similarity NPD2615 Phase 3
0.648 Remote Similarity NPD704 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data